AKT1 and colitis: Interestingly, Zhou et al. [28] found that IL-13 treatment could inhibit YAP expression via the PI3K-AKT-β-catenin pathway, while YAP can suppress macrophages polarize to M2 macrophages which leads to aggravating colitis [29].